CompletedNCT03098784

Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Montpellier
Principal Investigator
NICOLAS MOLINARI
University Hospital, Montpellier
Intervention
Exposure to aircraft exhaust(other)
Enrollment
472 target
Eligibility
18-65 years · All sexes
Timeline
20112012

Collaborators

Aix Marseille Université · LBM- Nanosecurity platform - CEA Grenoble · LR2N - Nanosecurity platform - CEA Grenoble

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03098784 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome

← Back to all trials